NewcelX prices USD 1.4 million private placement at USD 4.03 per share

Reuters2026/07/31 13:00

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

NewcelX priced a USD 1.4 million private placement at USD 4.03 per share, a 20% premium to the July 30 close.
Deal covers 347,134 common shares, with warrants for 347,134 shares at a USD 4.44 exercise price.
Closing targeted for about Aug. 14, subject to customary conditions.
Proceeds earmarked to advance NCEL-101 for type 1 diabetes, with Eledon Pharmaceuticals, with remaining funds for working capital.
Securities to be issued in an unregistered offering under Section 4(a)(2) and Regulation D.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NLS Pharmaceutics Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607310900PRIMZONEFULLFEED9801621) on July 31, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

NewcelX prices USD 1.4 million private placement at USD 4.03 per share

You may also like

Crypto prices